Short-chain fatty acids (SCFAs) mediated gut breast crosstalk in breast cancer: integrative network analysis of molecular signaling, immune infiltration and prognostic biomarkers
9 affiliations
- 1Molecular Microbiology and Infectious Diseases Research Unit, University of Tabuk
- 2Department of Community Health, College of Applied Medical Sciences, Northern Border University
- 3Department of Mathematical Sciences, College of Science, Princess Nourah bint Abdulrahman University
- 4Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU)
- 5Department of Food and Nutrition Sciences, College of Agricultural and Food Sciences, King Faisal University
- 6Department of Zoology, College of Science, King Saud University
- 7Faculty of Science, King Saud University
- 8Department of Animal Biology and Physiology, Laboratory of Animal Physiology, Faculty of Science, University of Yaoundé
- 9Neurosciences axis, Laboratory of Development and Maldevelopment, Department of Psychology, Faculty of Arts, Letters, and Social Science, University of Yaoundé 1
Abstract
Introduction: Breast cancer is a heterogeneous malignancy in which metabolic dysregulation, immune remodelling, and complex host microbiota interactions contribute to disease progression and therapeutic response. Emerging evidence suggests that gut microbiota-derived short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, may act as important molecular mediators linking the gut microbiome to systemic immune and tumor-associated signalling. However, the molecular networks through which SCFA-mediated signalling may influence breast cancer progression and the tumor immune microenvironment remains poorly characterized. This study aimed to investigate the potential regulatory mechanisms underlying the gut-breast axis by integrating SCFA host interaction networks in breast cancer transcriptomic, prognostic, immune infiltration, and drug gene interaction analyses.
Methods: The SCFA-host interactome was constructed from the combination of HMDB and PubChem data in a protein-protein interaction network. The identification of hub genes was conducted through topological analysis, followed by validation using TCGA-BRCA RNA-seq data, Kaplan-Meier Survival Analysis, TIMER2.0 immune analysis, and DGIdb repurposing analysis.
Results: The findings indicated that the genes STAT3, HIF1A, and IL6 served as key nodes connecting SCFA signalling and cancer formation. Selected SCFAs, such as propionate, have direct experimental evidence of involvement in the modulation of the JAK2/STAT3 pathway in breast cancer models, while butyrate has been associated with several breast cancer-related signalling and epigenetic mechanisms. Associations were most strongly identified in acetate which was mainly related to metabolic and immune regulatory pathways. This computational analysis did not give a quantitative ranking of the strength of interaction between SCFA and hub genes. In exploratory survival analysis without multiple-testing correction, increased STAT3 and HIF1A expression was associated with unfavourable relapse-free survival. SCFA-associated immune targets showed positive correlations with CD8+ T-cell infiltration.
Discussion: This study identifies the SCFA-host interactome as an essential regulatory network in breast cancer. Uncovering metabolic and signalling chokepoints such as STAT3 leads to the discovery of new biomarkers for prognosis and drug targets. This highlights the possibility of exploiting the gut-breast axis to increase immune cell penetration.
Related
- Molecular and cellular mechanisms of muscle–adipose tissue crosstalk driving sarcopenic obesity: an integrative review of human, animal, and in vitro models
- Gut microbiota–cancer crosstalk: emerging molecular targets for personalized cancer treatment- a comprehensive review
- Extracellular Vesicles in Molecular Crosstalk and Disease Pathogenesis: A Comprehensive Review on Mechanisms and Therapeutic Prospects
- Computational identification of candidate biomarkers and compounds associated with skeletal muscle insulin sensitivity improvement mediated by physical activity: an integrative multi-omics and computational chemistry study.
- FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications
BibTeX
@article{aziz2026shortchain,
title = {{Short-chain fatty acids (SCFAs) mediated gut breast crosstalk in breast cancer: integrative network analysis of molecular signaling, immune infiltration and prognostic biomarkers}},
author = {Tariq Aziz and Layla A. Alahmari and Nawal H. Siddig and Mai M. Almsaud and Fahad Al-Asmari and Huda A. Alqahtani and Rasha Alonaizan and Yolande Sandrine Mengue Ngadena},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1969874},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1969874/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Short-chain fatty acids (SCFAs) mediated gut breast crosstalk in breast cancer: integrative network analysis of molecular signaling, immune infiltration and prognostic biomarkers
AU - Tariq Aziz
AU - Layla A. Alahmari
AU - Nawal H. Siddig
AU - Mai M. Almsaud
AU - Fahad Al-Asmari
AU - Huda A. Alqahtani
AU - Rasha Alonaizan
AU - Yolande Sandrine Mengue Ngadena
PY - 2026
DA - 2026/10/28
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1969874
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1969874/full
AB - Introduction: Breast cancer is a heterogeneous malignancy in which metabolic dysregulation, immune remodelling, and complex host microbiota interactions contribute to disease progression and therapeutic response. Emerging evidence suggests that gut microbiota-derived short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, may act as important molecular mediators linking the gut microbiome to systemic immune and tumor-associated signalling. However, the molecular networks through which SCFA-mediated signalling may influence breast cancer progression and the tumor immune microenvironment remains poorly characterized. This study aimed to investigate the potential regulatory mechanisms underlying the gut-breast axis by integrating SCFA host interaction networks in breast cancer transcriptomic, prognostic, immune infiltration, and drug gene interaction analyses. Methods: The SCFA-host interactome was constructed from the combination of HMDB and PubChem data in a protein-protein interaction network. The identification of hub genes was conducted through topological analysis, followed by validation using TCGA-BRCA RNA-seq data, Kaplan-Meier Survival Analysis, TIMER2.0 immune analysis, and DGIdb repurposing analysis. Results: The findings indicated that the genes STAT3, HIF1A, and IL6 served as key nodes connecting SCFA signalling and cancer formation. Selected SCFAs, such as propionate, have direct experimental evidence of involvement in the modulation of the JAK2/STAT3 pathway in breast cancer models, while butyrate has been associated with several breast cancer-related signalling and epigenetic mechanisms. Associations were most strongly identified in acetate which was mainly related to metabolic and immune regulatory pathways. This computational analysis did not give a quantitative ranking of the strength of interaction between SCFA and hub genes. In exploratory survival analysis without multiple-testing correction, increased STAT3 and HIF1A expression was associated with unfavourable relapse-free survival. SCFA-associated immune targets showed positive correlations with CD8+ T-cell infiltration. Discussion: This study identifies the SCFA-host interactome as an essential regulatory network in breast cancer. Uncovering metabolic and signalling chokepoints such as STAT3 leads to the discovery of new biomarkers for prognosis and drug targets. This highlights the possibility of exploiting the gut-breast axis to increase immune cell penetration.
SN - 1664-3224
ER -